A 2018 review of sixteen studies of cannabis-centered medicines for neuropathic agony, the vast majority of which examined a cannabinoid preparing called nabiximols (brand name title Sativex; a mouth spray containing both THC and CBD which is authorised in certain nations around the world but not in The us), observed lower- to average-excellent evi